BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹273 Cr | ₹308 Cr | ₹279 Cr | ₹257 Cr | ₹226 Cr |
What is the latest Total Expenditure of BAL PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹308 Cr |
| Mar2023 | ₹279 Cr |
| Mar2022 | ₹257 Cr |
| Mar2021 | ₹226 Cr |
How is Total Expenditure of BAL PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹273 Cr | -11.34 | |
| Mar2024 | ₹308 Cr | 10.51 | |
| Mar2023 | ₹279 Cr | 8.45 | |
| Mar2022 | ₹257 Cr | 13.88 | |
| Mar2021 | ₹226 Cr | - | |
Compare Total Expenditure of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹121.2 Cr | -2.9% | 12% | -26% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -2.9% |
12% |
-26% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses